• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Dermatology

Medicare beneficiaries have a lower rate of delayed melanoma surgeries

byShirin BajajandAdam Whittington
April 14, 2015
in Dermatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The vast majority (>75%) of Medicare beneficiaries studied underwent excision of their melanoma within 1.5 months of their biopsy.

2. Surgical delay of melanoma resection, as measured by time between biopsy and surgical excision, was least likely in patients being managed by dermatologists.

Evidence Rating Level: 2 (Good)           

Study Rundown: Melanoma is a potentially deadly form of skin cancer that is an important cause of new cancer diagnoses in the United States. The primary modality for melanoma treatment is surgical excision, and while no studies have proven that delay in surgery affects mortality, there have also been no studies quantifying the extent of surgical delay in those affected by the disease. The authors of this study aimed to document surgical delay among Medicare beneficiaries with melanoma. About 1 in 5 patients in the study experienced a delay greater than 1.5 months between biopsy and excision for melanoma. Furthermore, patients ≥85 and with increased co-morbidity burden were most likely to experience delay. The large cohort size strengthened the study; however, the results were limited to those enrolled in the traditional Medicare fee-for service plan, which may have limited generalizability.

Click to read the study in JAMA Dermatology

Relevant Reading: Timely surgical follow-up for melanoma among Medicare beneficiaries

In-Depth [retrospective cohort]: The cohort consisted of 32,501 cases of melanoma. The cohort was primarily composed of white males ≥75 years old that had melanomas staged as in situ disease. Both the initial biopsy and excision were most commonly performed by dermatologists (88.4% and 41.9%, respectively) with the remaining excisions performed by general/plastic surgeons (30.5%), Mohs surgeons (9.1%) or primary care physicians (1.2%). Seventy eight percent of patients underwent excisional surgery within 1.5 months of biopsy. Of those who had surgery after 1.5 months, 8.1% of cases experienced a delay longer than 3 months. As compared to those younger than 65 years old, patients ≥85 had significantly increased risk-adjusted surgical delay longer than 1.5 months (odds ratio [OR], 1.28 [95% CI, 1.05-1.55]; P = .02), as did those with a prior melanoma (OR, 1.20 [95% CI, 1.08-1.34]; P = .001) and those with increased comorbidity burden (OR, 1.18 [95% CI, 1.09-1.27]; P < .001). The lowest likelihood of delay was seen in melanomas biopsied and excised by a dermatologist (16% probability, 95% CI, 14%-18%). In contrast, the highest likelihood of delay was seen when biopsy was performed by a non-dermatologist and then excised by a primary care physician (31% probability, 95% CI 24%-37%).

RELATED REPORTS

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

#VisualAbstract: Melanoma is projected to remain an important global health concern in 2040, with high incidence rates in fair-skinned populations of European descent

#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers

Image: CC/Wiki/KGH

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: melanoma
Previous Post

USPSTF finds insufficient evidence for improved mortality from diabetes screening

Next Post

2 Minute Medicine Rewind April 6 – April 12, 2015

RelatedReports

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue
StudyGraphics

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

April 28, 2022
#VisualAbstract: Melanoma is projected to remain an important global health concern in 2040, with high incidence rates in fair-skinned populations of European descent
StudyGraphics

#VisualAbstract: Melanoma is projected to remain an important global health concern in 2040, with high incidence rates in fair-skinned populations of European descent

April 14, 2022
#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers
StudyGraphics

#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers

April 12, 2022
#VisualAbstract: Melanoma may be considerably over-diagnosed in white patients in the US
StudyGraphics

#VisualAbstract: Melanoma may be considerably over-diagnosed in white patients in the US

March 24, 2022
Next Post
Blood type correlates with egg reserve in infertile women

2 Minute Medicine Rewind April 6 – April 12, 2015

Esmolol-induced heart rate reduction may aid in septic shock

Increasing post-ICU physical therapy does not improve functional status [RECOVER trial]

Industry influences on expert panels contribute to over-diagnosis

Study participants prefer less demanding consent

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Wellness Check: Mental Health
  • #VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma
  • #VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.